澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - follitropin alfa, quantity: 10.92 microgram - diluent, not applicable - excipient ingredients: water for injections - treatment of anovulatory infertility in women after inadequate response to clomiphene or where clomiphene in contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - follitropin alfa, quantity: 5.46 microgram - diluent, not applicable - excipient ingredients: water for injections - treatment of anovulatory infertility in women after inadequate response to clomiphene or where clomiphene in contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - follitropin alfa, quantity: 2.73 microgram - diluent, not applicable - excipient ingredients: water for injections - treatment of anovulatory infertility in women after inadequate response to clomiphene or where clomiphene in contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bsv bioscience malaysia sdn. bhd. - urofollitropin -

马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bsv bioscience malaysia sdn. bhd. - urofollitropin -

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - fsh-porcine - parenteral liquid/solution/suspension - fsh-porcine hormone-follicle stimulating active 400.0 mg/20ml - endocrine system - cow | heifer (young female cattle) | bovine | cow young | female cattle - induce superovulation

美国 - 英文 - NLM (National Library of Medicine)

organon llc - follitropin (unii: 076whw89tw) (follitropin - unii:076whw89tw) - follistim® aq cartridge (follitropin beta) injection, is indicated: in women for: prior to initiation of treatment with follistim aq cartridge: - women should have a complete gynecologic and endocrinologic evaluation. - primary ovarian failure should be excluded. - the possibility of pregnancy should be excluded. - tubal patency should be demonstrated. - the fertility status of the male partner should be evaluated. prior to initiation of treatment with follistim aq cartridge: - women should have a complete gynecologic and endocrinologic evaluation and diagnosis of cause of infertility. - the possibility of pregnancy should be excluded. - the fertility status of the male partner should be evaluated. in men for: prior to initiation of treatment with follistim aq cartridge: - men should have a complete medical and endocrinologic evaluation. - hypogonadotropic hypogonadism should be confirmed and primary testicular failure should be excluded. - serum testosterone levels should be normalized with human chorionic gonadotropin (hcg) treatment. - the fertility status of the female partner should be evaluated. follistim aq cartridge is contraindicated in women and men who exhibit: - prior hypersensitivity to recombinant hfsh products - high levels of fsh indicating primary gonadal failure - presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders) [see indications and usage (1.1, 1.2, 1.3)] - hypersensitivity reactions to streptomycin or neomycin. follistim aq may contain traces of these antibiotics - tumors of the ovary, breast, uterus, testis, hypothalamus or pituitary gland follistim aq cartridge is also contraindicated in women who exhibit: - pregnancy [see use in specific populations (8.1)] - heavy or irregular vaginal bleeding of undetermined origin - ovarian cysts or enlargement not due to polycystic ovary syndrome (pcos) risk summary follistim aq cartridge is contraindicated for use in pregnant women and offers no benefit during pregnancy. risk summary it is not known whether this drug is excreted in human milk. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for follistim aq cartridge and any potential adverse effects on the breastfed child from follistim aq cartridge or from the underlying maternal condition. follistim aq cartridge is not indicated for use in pediatric patients. clinical studies have not been conducted in the pediatric population. clinical studies of follistim aq cartridge have not been conducted in patients 65 years of age and older.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - follitropin alfa, quantity: 600 iu/ml - injection, powder for - excipient ingredients: dibasic sodium phosphate dihydrate; sodium hydroxide; sucrose; phosphoric acid; monobasic sodium phosphate - the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

ferring ireland ltd - urofollitropin - pdr+solv for soln for inj - 75 international unit - urofollitropin

欧盟 - 英文 - EMA (European Medicines Agency)

n.v. organon - corifollitropin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - sex hormones and modulators of the genital system, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program.elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).